JERUSALEM, June 5, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that Mr. Ophir Shahaf , Chief Executive Officer, will be presenting at the third annual Connecticut-Israel Technology Summit on June 12th at The Oakdale Theater in Wallingford, CT.
Mr. Shahaf will discuss the six current portfolio companies in Hadasit Bio-Holdings as part of the "Introductions of Israeli Biomed Companies" segment of the conference. In addition to Hadasit Bio-Holdings, there are currently 20 community leaders, businesses, and institutions slated to participate, including Hartford Hospital, Gartner, Briefcam, The Hartford, United Technologies Corporation, the University of Connecticut, the Department of Economic and Community Development, and the Binational Industrial Research and Development Foundation.
"I am eager and excited to present our story to this targeted group of businesses and individuals looking to advance partnerships with Israeli companies," said Mr. Shahaf. "Our unique business model and relationship to the Hadassah Hospitals in Israel has afforded us the opportunity to obtain world-class scientific research, turn this research into fully functioning companies and then further advance the companies through the help of our public company vehicle. I look forward to discussing our story and potential strategic partnerships with the attendees of the conference."
The conference, which begins at 11 a.m. and ends at 6 p.m., will focus on building partnerships between Israeli companies and Connecticut. The organizers' goal is to
|SOURCE Hadasit Bio-Holdings Ltd.|
Copyright©2012 PR Newswire.
All rights reserved